Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)

ClinicalTrials.gov ID: NCT04411641

Public ClinicalTrials.gov record NCT04411641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS Secondary Objective: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety and tolerability of SAR442168 To evaluate population pharmacokinetics (PK) of SAR442168 and relevant metabolites in NRSPMS and its relationship to efficacy and safety To evaluate pharmacodynamics (PD) of SAR442168

Study identification

NCT ID
NCT04411641
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
1,131 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 24, 2020 (Actual)
Primary completion
Aug 29, 2024 (Actual)
Completion
Aug 29, 2024 (Actual)
Last update posted
Jul 2, 2025

2020 – 2024

United States locations

U.S. sites
51
U.S. states
27
U.S. cities
47
Facility City State ZIP Site status
University of Alabama MS Center-Site Number:8400013 Birmingham Alabama 35233 —
Center for Neurology and Spine-Site Number:8400089 Phoenix Arizona 84018 —
Arcadia Neurology Center-Site Number:8400070 Arcadia California 91006 —
UC San Diego ACTRI-Site Number:8400101 La Jolla California 92037 —
Collaborative Neuroscience Research-Site Number:8400045 Long Beach California 90806 —
Multiple Sclerosis Center-Site Number:8400143 Los Angeles California 90033 —
University of San Francisco, Sandler Neurosciences Center-Site Number:8400137 San Francisco California 94158 —
Harbor UCLA-Site Number:8400088 Torrance California 90502 —
Regina Berkovich, MD, PhD-Site Number:8400059 West Hollywood California 90048 —
Mountain Neurological Research Center, Inc.-Site Number:8400128 Basalt Colorado 81621 —
University of Colorado-Site Number:8400012 Denver Colorado 80262 —
Advanced Neurosciences Research-Site Number:8400025 Fort Collins Colorado 80528 —
South Florida Neurology Associates-Site Number:8400029 Boca Raton Florida 33487 —
Neurology Associates, PA-Site Number:8400004 Maitland Florida 32761 —
Aqualane Clinical Research-Site Number:8400027 Naples Florida 34105 —
Axiom Clinical Research of Florida-Site Number:8400001 Tampa Florida 33609-4052 —
University of South Florida-Site Number:8400006 Tampa Florida 33612 —
Meridian Clinical Research-Site Number:8400003 Savannah Georgia 31406 —
Consultants In Neurology-Site Number:8400011 Northbrook Illinois 60062 —
University of Kansas Medical Center-Site Number:8400023 Kansas City Kansas 66160-7321 —
CHI Saint Joseph Medical Group Neurology-Site Number:8400110 Lexington Kentucky 40509 —
Tufts Medical Center-Site Number:8400072 Boston Massachusetts 02111 —
University of Massachusetts-Site Number:8400014 Worcester Massachusetts 01655 —
Wayne State University-Site Number:8400046 Detroit Michigan 48201 —
The Memorial Hospital-Site Number:8400033 Owosso Michigan 48867 —
Minneapolis Clinic of Neurology-Site Number:8400051 Minneapolis Minnesota 55422 —
Mayo Clinic-Site Number:8400111 Rochester Minnesota 55905 —
Missouri Baptist Medical Center-Site Number:8400019 St Louis Missouri 63131 —
Lou Ruvo Center for Brain Health-Site Number:8400117 Las Vegas Nevada 89106 —
Holy Name Hospital-Site Number:8400104 Teaneck New Jersey 07666 —
University of New Mexico-Site Number:8400032 Albuquerque New Mexico 87131 —
Icahn School of Medicine at Mount Sinai (Department of Endoc-Site Number:8400038 New York New York 10029-6501 —
Neurology Associates of Stony Brook-Site Number:8400042 Stony Brook New York 11794 —
Meridian Clinical Research, LLC-Site Number:8400005 Raleigh North Carolina 27607 —
Sanford Brain & Spine Center-Site Number:8400126 Fargo North Dakota 58103 —
University Hospitals CMC-Site Number:8400083 Cleveland Ohio 44106 —
Cleveland Clinic-Site Number:8400125 Cleveland Ohio 44195 —
Optimed Research, LTD-Site Number:8400147 Columbus Ohio 43235 —
Neurology Specialists-Site Number:8400002 Dayton Ohio 45417 —
Columbus Neuroscience-Site Number:8400010 Westerville Ohio 40382 —
Providence Multiple Sclerosis Center-Site Number:8400020 Portland Oregon 97225 —
Perelman Center for Advanced Medicine-Site Number:8400142 Philadelphia Pennsylvania 19104 —
Jefferson Neurology Associates-Site Number:8400016 Philadelphia Pennsylvania 19107 —
Premier Neurology-Site Number:8400069 Greer South Carolina 29650 —
Mountain View Clinical Research-Site Number:8400024 Greer South Carolina 29651-1817 —
Neurology Clinic, PC-Site Number:8400087 Cordova Tennessee 38018 —
Advanced Neuroscience Center-Site Number:8400035 Franklin Tennessee 37064 —
Baylor College of Medicine-Site Number:8400136 Houston Texas 77030 —
Neurology Center of San Antonio-Site Number:8400036 San Antonio Texas 78258 —
University Of Vermont College Of Medicine-Site Number:8400130 Burlington Vermont 05401 —
Medical College of Wisconsin-Site Number:8400028 Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 255 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04411641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2025 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04411641 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →